logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

JW Kim

Catholic University of Daegu
H指数:35
被引数:6,397

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rheumatoid factor and anti-cyclic citrullinated peptide antibody levels decline in rheumatoid arthritis patients treated with Janus kinase inhibitors or biological disease-modifying anti-rheumatic drugs

类风湿因子和抗环状瓜氨酸肽抗体水平在应用JAK抑制剂或生物制剂改善病情的抗风湿药物治疗的类风湿关节炎患者中下降。

JOURNAL OF RHEUMATIC DISEASES
IF0
2025-10-010
OAAI
Kim, Bo Young; Kim, Ji-Won; Lee, Hwajeong; Park, Sung-Hoon; Kim, Seong-Kyu; Choe, Jung-Yoon
Randomized Phase III Trial of Adjuvant Radiation versus Chemoradiation in Intermediate-Risk, Early-stage Cervical Cancer following Radical Hysterectomy and Lymphadenectomy: Results from NRG Oncology/GOG-263/KGOG1008

NRG Oncology/GOG-263/KGOG1008研究：在行根治性子宫切除术和淋巴结清扫术后的中危、早期宫颈癌中，比较辅助放疗与化放疗的随机III期临床试验结果

Annals of Oncology
IF65.4
2025-09-120
PREAI
S.Y. Ryu; W. Deng; K. Albuquerque; W-J Koh; J. Mayadev; A. Heugel; B-J Kim; D-Y Kim; C-H Cho; J-W Kim; J.H. No; R.S. Mannel; K. Miller; D. Fabian; D.M. Chase; K.M. Gil; W. Small; W. Rodgers; C.A. Leath; B.J. Monk
Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort

使用血清学和临床因素开发类风湿关节炎相关间质性肺疾病进展预测模型：前瞻性KORAIL队列研究

SEMINARS IN ARTHRITIS AND RHEUMATISM
IF4.4
2025-06-130
PRE
Sung Hae Chang; Misti L. Paudel; Gregory C. McDermott; Qianru Zhang; Sho Fukui; Minuk Kim; You-Jung Ha; Jeong Seok Lee; Sung Won Lee; Chan Ho Park; Ji-Won Kim; Jang Woo Ha; Sang Wan Chung; Eun Ha Kang; Yeon-Ah Lee; Yong-Beom Park; Jung-Yoon Choe; Eun Young Lee; Jeffrey A. Sparks
Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice

运动诱导的CLCF1减轻小鼠年龄相关的肌肉和骨骼衰退

NATURE COMMUNICATIONS
IF15.7
2025-05-220
OA
Kang, Jae Sook; Kim, Jung Ha; Kim, Min Ju; Min, Byungkuk; Lee, Seung-Min; Go, Ga-Yeon; Kim, Ji-Won; Kim, Seongwan; Kwak, Ju Yeon; Chun, Sung-Wook; Song, Wook; Moon, Hyo Youl; Chung, Sun Gun; Park, Dong-Ho; Park, Ji Hoon; Kim, Chuna; Lee, Kwang-Pyo; Kwon, Eun-Soo; Kim, Nacksung; Yang, Yong Ryoul
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials

二线以氟嘧啶为基础的化疗在晚期胆道癌中的应用：一项基于随机试验个体患者数据的Meta分析

CANCER RESEARCH AND TREATMENT
IF3.8
2024-10-170
OA
Hyung, Jaewon; Kang, Minsu; Kim, Ilhwan; Kim, Kyu-pyo; Ryoo, Baek-Yeol; Cheon, Jaekyung; Ryu, Hyewon; Lee, Ji Sung; Kim, Ji-Won; Choi, In Sil; Park, Jin Hyun; Abou-Alfa, Ghassan K.; Kim, Jin Won; Yoo, Changhoon
Pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/APGOT-OV3)

帕博利珠单抗联合仑伐替尼（PL）在复发性透明细胞妇科肿瘤（CCGC）中的疗效：II期LARA试验（GCGS-OV4/APGOT-OV3）

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Ngoi, N.; Lee, J-Y.; Lim, D.; Thian, Y. L.; Lim, Y. W.; Chan, J. J.; Chay, W. Y.; Zhang, Z.; Gopinathan, A.; Lim, S. E.; Low, J.; Ng, J.; Tong, P.; Lee, Y. J.; Park, J.; Kim, J-W.; Zhu, J.; Tai, B. C.; Kim, B-G.; Tan, D. S.
Final analysis of KGOG3046/TRU-D: A phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer

KGOG3046/TRU-D的最终分析：一项关于度伐利尤单抗和特瑞普利单抗联合一线新辅助化疗治疗晚期卵巢癌患者的II期研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Park, J.; Joung, J-G.; Park, E.; Lee, J.; Lim, M. C.; Kim, B-G.; Kim, J-W.; Shin, S.; Kim, S.; Choi, C. H.; Kim, H. S.; Park, S. Y.; Lee, J-Y.
Safety and tolerability of durvalumab (D) plus carboplatin/paclitaxel (CP) plus bevacizumab (B) followed by D, B plus olaparib (O) maintenance (mtx) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) without a tumour BRCA1/BRCA2 mutation (non-tBRCAm) in the phase III DUO-O trial

在DUO-O III期试验中，评估 durvalumab (D) 联合 carboplatin/paclitaxel (CP) 及 bevacizumab (B) 诱导治疗后，再给予 D、B 联合 olaparib (O) 维持治疗（mtx）在无肿瘤 BRCA1/BRCA2 突变（non-tBRCAm）的新诊断晚期卵巢癌（AOC）患者中的安全性与耐受性。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Aghajanian, C.; Schmalfeldt, B.; Okamoto, A.; Reuss, A.; Kim, J-W.; Ospina, G. Marquina; Ayhan, A.; Salutari, V.; Lebreton, C.; Labudovic, D.; Tognon, G.; Chudecka-Glaz, A. M.; Berger, R.; Lheureux, S.; Henry, S.; Burges, A.; Wenham, R. M.; Nishio, S.; Marshall, L.; Harter, P.

研究方向

暂未获取到该数据
J
Jung‐Yoon Choe
H 指数:47论文数:349被引数:7,928
K
Kun‐Ho Yoon
H 指数:65论文数:557被引数:2.0万
S
Seong‐Kyu Kim
H 指数:34论文数:195被引数:3,732
K
Kyung-Woo Lee
H 指数:58论文数:639被引数:1.2万
H
Hei Sung Kim
H 指数:40论文数:415被引数:5,844
J
Ji Hyeon Ju
H 指数:52论文数:327被引数:9,750
J
Jennifer Lee
H 指数:51论文数:434被引数:1.1万
S
Sung‐Hwan Park
H 指数:70论文数:646被引数:1.7万
S
Sung‐Hoon Park
H 指数:24论文数:102被引数:1,750
H
Hwajeong Lee
H 指数:20论文数:94被引数:1,770